Extract from the Register of European Patents

EP About this file: EP2255825

EP2255825 - COMPOSITION FOR PREVENTING OR TREATING BRAIN DISEASES [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  03.01.2014
Database last updated on 14.03.2026
Most recent event   Tooltip03.01.2014Application deemed to be withdrawnpublished on 05.02.2014  [2014/06]
Applicant(s)For all designated states
Regeron, Inc.
B-403 BIC Hi-Tech Venture Town 198-53 Hupyung-Dong Chuncheon-si
Gangwon-do 200-161 / KR
[2010/48]
Inventor(s)01 / LEE, Heejae
102-803 Kangbyunkoaroo Apt. Udu-dong
Chuncheon-si Gangwon-do 200-150 / KR
02 / BYUN, Jong-Seon
101-1108 Dongbu Apt. Udu-dong
Chuncheon-si Gangwon-do 200-770 / KR
03 / LEE, Kyunyoung
710-304 Jugong 7-danji Apt. Hupyeong-dong
Chuncheon-si Gangwon-do 200-160 / KR
04 / BAIK, Sangjung
403-408 Sekyung 4-cha Apt. 885-1 Hupyeong-dong
Chuncheon-si Gangwon-do 200-160 / KR
05 / OH, Dahlkyun
102-1502 Kukdong Neulpureun Apt. 595 Hupyeong-dong
Chuncheon-si Gangwon-do 200-160 / KR
 [2010/48]
Representative(s)Scholz, Volker, et al
Boehmert & Boehmert
Anwaltspartnerschaft mbB
Pettenkoferstrasse 22
80336 München / DE
[N/P]
Former [2013/27]Scholz, Volker, et al
Boehmert & Boehmert
Pettenkoferstrasse 20-22
80336 München / DE
Former [2010/48]Winkler, Andreas Fritz Ernst
Forrester & Boehmert Pettenkoferstrasse 20-22
80336 München / DE
Application number, filing date09704175.023.01.2009
[2010/48]
WO2009KR00364
Priority number, dateKR2008000820725.01.2008         Original published format: KR 20080008207
[2010/48]
Filing languageKO
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2009093864
Date:30.07.2009
Language:KO
[2009/31]
Type: A2 Application without search report 
No.:EP2255825
Date:01.12.2010
Language:EN
[2010/48]
Search report(s)International search report - published on:KR22.10.2009
(Supplementary) European search report - dispatched on:EP16.08.2011
ClassificationIPC:A61K38/22, A61P25/00, A61P25/24, A61P25/28
[2011/36]
CPC:
A61K38/22 (EP,KR,US); A61K35/12 (KR); A61K35/60 (KR);
A61P25/00 (EP); A61P25/14 (EP); A61P25/16 (EP);
A61P25/18 (EP); A61P25/24 (EP); A61P25/28 (EP);
A61P43/00 (EP); A23V2002/00 (EP,US) (-)
C-Set:
A23V2002/00, A23V2200/322 (EP,US)
Former IPC [2010/48]A61K38/22
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/48]
TitleGerman:ZUSAMMENSETZUNG ZUR PRÄVENTION ODER BEHANDLUNG VON GEHIRNERKRANKUNGEN[2010/48]
English:COMPOSITION FOR PREVENTING OR TREATING BRAIN DISEASES[2010/48]
French:COMPOSITION POUR PRÉVENIR OU TRAITER DES MALADIES DU CERVEAU[2010/48]
Entry into regional phase25.08.2010Translation filed 
25.08.2010National basic fee paid 
25.08.2010Search fee paid 
25.08.2010Designation fee(s) paid 
25.08.2010Examination fee paid 
Examination procedure25.08.2010Examination requested  [2010/48]
05.03.2012Amendment by applicant (claims and/or description)
01.08.2013Application deemed to be withdrawn, date of legal effect  [2014/06]
30.09.2013Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2014/06]
Fees paidRenewal fee
14.01.2011Renewal fee patent year 03
26.01.2012Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
31.01.201305   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X] US2004198658  (OLSEN HENRIK S et al.) [X] 1-9 * paragraph [0008]; example 1; claims 16, 29, 103; sequences 1,2 * * paragraph [0372] - paragraph [0388] *
 [A] WO0108697  (ZYMOGENETICS INC et al.) [A] 1-9 * page 3, line 22 - line 33; claims 1-3 *
 [I]   ZHANG KE-ZHOU ET AL: "Stanniocalcin: A molecular guard of neurons during cerebral ischemia", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, WASHINGTON, DC; US, vol. 97, no. 7, 28 March 2000 (2000-03-28), pages 3637 - 3642, XP002232251, ISSN: 0027-8424, DOI: 10.1073/PNAS.070045897 [I] 1-9 * abstract * * page 3641, column r, paragraph l; figures 3-7 *

DOI:   http://dx.doi.org/10.1073/pnas.070045897
 [I]   ITO DAISUKE ET AL: "Characterization of stanniocalcin 2, a novel target of the mammalian unfolded protein response with cytoprotective properties", MOLECULAR AND CELLULAR BIOLOGY, vol. 24, no. 21, November 2004 (2004-11-01), pages 9456 - 9469, XP002653723, ISSN: 0270-7306 [I] 1-9 * abstract * * page 9464, column r, paragraph 2 - page 9466, column r, paragraph 1; figures 8-10 *

DOI:   http://dx.doi.org/10.1128/MCB.24.21.9456-9469.2004
 [I]   ZHANG KE-ZHOU ET AL: "High expression of stanniocalcin in differentiated brain neurons", AMERICAN JOURNAL OF PATHOLOGY, AMERICAN SOCIETY FOR INVESTIGATIVE PATHOLOGY, US, vol. 153, no. 2, 1 August 1998 (1998-08-01), pages 439 - 445, XP002232245, ISSN: 0002-9440 [I] 1-9 * abstract * * page 439, column r, paragraph l * * page 444, column r, paragraph 4 - paragraph 5 *
 [T]   BYUN J S ET AL: "Neuroprotective effects of stanniocalcin 2 following kainic acid-induced hippocampal degeneration in ICR mice", PEPTIDES, ELSEVIER, AMSTERDAM, vol. 31, no. 11, 1 November 2010 (2010-11-01), pages 2094 - 2099, XP027408860, ISSN: 0196-9781, [retrieved on 20100814] [T] * the whole document *
International search[X]   KE-ZHOU ZHANG ET AL.: "Stanniocalcin: A molecular guard of neurons during cerebral ischemia", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 97, no. 7, 2000, pages 3637 - 3642, XP002232251 [X]

DOI:   http://dx.doi.org/10.1073/pnas.070045897
 [X]   J. MICHAEL CONLON: "Singular contributions of fish neuroendocrinology to mammalian regulatory peptide research", REGULAR PEPTIDES, vol. 93, 2000, pages 3 - 13, XP008140902 [X]

DOI:   http://dx.doi.org/10.1016/S0167-0115(00)00172-5
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.